XXII International Conference on Mechanics in Medicine and Biology - Abstracts Book

This book contain the abstracts presented the XXII ICMMB, held in Bologna in September 2022. The abstracts are divided following the sessions scheduled during the conference

A Novel Ontology and Machine Learning Driven Hybrid Clinical Decision Support Framework for Cardiovascular Preventative Care

Clinical risk assessment of chronic illnesses is a challenging and complex task which requires the utilisation of standardised clinical practice guidelines and documentation procedures in order to ensure consistent and efficient patient care. Conventional cardiovascular decision support systems have significant limitations, which include the inflexibility to deal with complex clinical processes, hard-wired rigid architectures based on branching logic and the inability to deal with legacy patient data without significant software engineering work. In light of these challenges, we are proposing a novel ontology and machine learning-driven hybrid clinical decision support framework for cardiovascular preventative care. An ontology-inspired approach provides a foundation for information collection, knowledge acquisition and decision support capabilities and aims to develop context sensitive decision support solutions based on ontology engineering principles. The proposed framework incorporates an ontology-driven clinical risk assessment and recommendation system (ODCRARS) and a Machine Learning Driven Prognostic System (MLDPS), integrated as a complete system to provide a cardiovascular preventative care solution. The proposed clinical decision support framework has been developed under the close supervision of clinical domain experts from both UK and US hospitals and is capable of handling multiple cardiovascular diseases. The proposed framework comprises of two novel key components: (1) ODCRARS (2) MLDPS. The ODCRARS is developed under the close supervision of consultant cardiologists Professor Calum MacRae from Harvard Medical School and Professor Stephen Leslie from Raigmore Hospital in Inverness, UK. The ODCRARS comprises of various components, which include: (a) Ontology-driven intelligent context-aware information collection for conducting patient interviews which are driven through a novel clinical questionnaire ontology. (b) A patient semantic profile, is generated using patient medical records which are collated during patient interviews (conducted through an ontology-driven context aware adaptive information collection component). The semantic transformation of patients’ medical data is carried out through a novel patient semantic profile ontology in order to give patient data an intrinsic meaning and alleviate interoperability issues with third party healthcare systems. (c) Ontology driven clinical decision support comprises of a recommendation ontology and a NICE/Expert driven clinical rules engine. The recommendation ontology is developed using clinical rules provided by the consultant cardiologist from the US hospital. The recommendation ontology utilises the patient semantic profile for lab tests and medication recommendation. A clinical rules engine is developed to implement a cardiac risk assessment mechanism for various cardiovascular conditions. The clinical rules engine is also utilised to control the patient flow within the integrated cardiovascular preventative care solution. The machine learning-driven prognostic system is developed in an iterative manner using state of the art feature selection and machine learning techniques. A prognostic model development process is exploited for the development of MLDPS based on clinical case studies in the cardiovascular domain. An additional clinical case study in the breast cancer domain is also carried out for the development and validation purposes. The prognostic model development process is general enough to handle a variety of healthcare datasets which will enable researchers to develop cost effective and evidence based clinical decision support systems. The proposed clinical decision support framework also provides a learning mechanism based on machine learning techniques. Learning mechanism is provided through exchange of patient data amongst the MLDPS and the ODCRARS. The machine learning-driven prognostic system is validated using Raigmore Hospital's RACPC, heart disease and breast cancer clinical case studies

Acute myocardial infarction patient data to assess healthcare utilization and treatments.

The goal of this study is to use a data mining framework to assess the three main treatments for acute myocardial infarction: thrombolytic therapy, percutaneous coronary intervention (percutaneous angioplasty), and coronary artery bypass surgery. The need for a data mining framework in this study arises because of the use of real world data rather than highly clean and homogenous data found in most clinical trials and epidemiological studies. The assessment is based on determining a profile of patients undergoing an episode of acute myocardial infarction, determine resource utilization by treatment, and creating a model that predicts each treatment resource utilization and cost. Text Mining is used to find a subset of input attributes that characterize subjects who undergo the different treatments for acute myocardial infarction as well as distinct resource utilization profiles. Classical statistical methods are used to evaluate the results of text clustering. The features selected by supervised learning are used to build predictive models for resource utilization and are compared with those features selected by traditional statistical methods for a predictive model with the same outcome. Sequence analysis is used to determine the sequence of treatment of acute myocardial infarction. The resulting sequence is used to construct a probability tree that defines the basis for cost effectiveness analysis that compares acute myocardial infarction treatments. To determine effectiveness, survival analysis methodology is implemented to assess the occurrence of death during the hospitalization, the likelihood of a repeated episode of acute myocardial infarction, and the length of time between reoccurrence of an episode of acute myocardial infarction or the occurrence of death. The complexity of this study was mainly based on the data source used: administrative data from insurance claims. Such data source was not originally designed for the study of health outcomes or health resource utilization. However, by transforming record tables from many-to-many relations to one-to-one relations, they became useful in tracking the evolution of disease and disease outcomes. Also, by transforming tables from a wide-format to a long-format, the records became analyzable by many data mining algorithms. Moreover, this study contributed to field of applied mathematics and public health by implementing a sequence analysis on consecutive procedures to determine the sequence of events that describe the evolution of a hospitalization for acute myocardial infarction. This same data transformation and algorithm can be used in the study of rare diseases whose evolution is not well understood

A Powerful Paradigm for Cardiovascular Risk Stratification Using Multiclass, Multi-Label, and Ensemble-Based Machine Learning Paradigms: A Narrative Review

Background and Motivation: Cardiovascular disease (CVD) causes the highest mortality globally. With escalating healthcare costs, early non-invasive CVD risk assessment is vital. Conventional methods have shown poor performance compared to more recent and fast-evolving Artificial Intelligence (AI) methods. The proposed study reviews the three most recent paradigms for CVD risk assessment, namely multiclass, multi-label, and ensemble-based methods in (i) office-based and (ii) stress-test laboratories. Methods: A total of 265 CVD-based studies were selected using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) model. Due to its popularity and recent development, the study analyzed the above three paradigms using machine learning (ML) frameworks. We review comprehensively these three methods using attributes, such as architecture, applications, pro-and-cons, scientific validation, clinical evaluation, and AI risk-of-bias (RoB) in the CVD framework. These ML techniques were then extended under mobile and cloud-based infrastructure. Findings: Most popular biomarkers used were office-based, laboratory-based, image-based phenotypes, and medication usage. Surrogate carotid scanning for coronary artery risk prediction had shown promising results. Ground truth (GT) selection for AI-based training along with scientific and clinical validation is very important for CVD stratification to avoid RoB. It was observed that the most popular classification paradigm is multiclass followed by the ensemble, and multi-label. The use of deep learning techniques in CVD risk stratification is in a very early stage of development. Mobile and cloud-based AI technologies are more likely to be the future. Conclusions: AI-based methods for CVD risk assessment are most promising and successful. Choice of GT is most vital in AI-based models to prevent the RoB. The amalgamation of image-based strategies with conventional risk factors provides the highest stability when using the three CVD paradigms in non-cloud and cloud-based frameworks

Machine Learning/Deep Learning in Medical Image Processing

Many recent studies on medical image processing have involved the use of machine learning (ML) and deep learning (DL). This special issue, “Machine Learning/Deep Learning in Medical Image Processing”, has been launched to provide an opportunity for researchers in the area of medical image processing to highlight recent developments made in their fields with ML/DL. Seven excellent papers that cover a wide variety of medical/clinical aspects are selected in this special issue

A cumulative index to the 1977 issues of a continuing bibliography on aerospace medicine and biology

This publication is a cumulative index to the abstracts contained in the Supplements 164 through 175 of Aerospace Medicine and Biology: A Continuing Bibliography. It includes three indexes-- subject, personal author, and corporate source

Decision support continuum paradigm for cardiovascular disease: Towards personalized predictive models

Clinical decision making is a ubiquitous and frequent task physicians make in their daily clinical practice. Conventionally, physicians adopt a cognitive predictive modelling process (i.e. knowledge and experience learnt from past lecture, research, literature, patients, etc.) for anticipating or ascertaining clinical problems based on clinical risk factors that they deemed to be most salient. However, with the inundation of health data and the confounding characteristics of diseases, more effective clinical prediction approaches are required to address these challenges. Approximately a few century ago, the first major transformation of medical practice took place as science-based approaches emerged with compelling results. Now, in the 21st century, new advances in science will once again transform healthcare. Data science has been postulated as an important component in this healthcare reform and has received escalating interests for its potential for ‘personalizing’ medicine. The key advantages of having personalized medicine include, but not limited to, (1) more effective methods for disease prevention, management and treatment, (2) improved accuracy for clinical diagnosis and prognosis, (3) provide patient-oriented personal health plan, and (4) cost containment. In view of the paramount importance of personalized predictive models, this thesis proposes 2 novel learning algorithms (i.e. an immune-inspired algorithm called the Evolutionary Data-Conscious Artificial Immune Recognition System, and a neural-inspired algorithm called the Artificial Neural Cell System for classification) and 3 continuum-based paradigms (i.e. biological, time and age continuum) for enhancing clinical prediction. Cardiovascular disease has been selected as the disease under investigation as it is an epidemic and major health concern in today’s world. We believe that our work has a meaningful and significant impact to the development of future healthcare system and we look forward to the wide adoption of advanced medical technologies by all care centres in the near future.Open Acces

Computational methods for physiological data

Thesis (Ph. D.)--Harvard-MIT Division of Health Sciences and Technology, 2009.Author is also affiliated with the MIT Dept. of Electrical Engineering and Computer Science. Cataloged from PDF version of thesis.Includes bibliographical references (p. 177-188).Large volumes of continuous waveform data are now collected in hospitals. These datasets provide an opportunity to advance medical care, by capturing rare or subtle phenomena associated with specific medical conditions, and by providing fresh insights into disease dynamics over long time scales. We describe how progress in medicine can be accelerated through the use of sophisticated computational methods for the structured analysis of large multi-patient, multi-signal datasets. We propose two new approaches, morphologic variability (MV) and physiological symbolic analysis, for the analysis of continuous long-term signals. MV studies subtle micro-level variations in the shape of physiological signals over long periods. These variations, which are often widely considered to be noise, can contain important information about the state of the underlying system. Symbolic analysis studies the macro-level information in signals by abstracting them into symbolic sequences. Converting continuous waveforms into symbolic sequences facilitates the development of efficient algorithms to discover high risk patterns and patients who are outliers in a population. We apply our methods to the clinical challenge of identifying patients at high risk of cardiovascular mortality (almost 30% of all deaths worldwide each year). When evaluated on ECG data from over 4,500 patients, high MV was strongly associated with both cardiovascular death and sudden cardiac death. MV was a better predictor of these events than other ECG-based metrics. Furthermore, these results were independent of information in echocardiography, clinical characteristics, and biomarkers.(cont.) Our symbolic analysis techniques also identified groups of patients exhibiting a varying risk of adverse outcomes. One group, with a particular set of symbolic characteristics, showed a 23 fold increased risk of death in the months following a mild heart attack, while another exhibited a 5 fold increased risk of future heart attacks.by Zeeshan Hassan Syed.Ph.D